Profile cover photo
Profile photo
BioSculpture Technology, Inc.
1 follower
1 follower
About
Posts

Post has attachment
BioSculpture Technology's CEO explains the rationale for and potential impact of endoscopic visceral lipectomy

Post has attachment
BioSculpture Technology, Inc.'s Endoscopic Visceral Lipectomy project.

Post has attachment
IPO to Develop New Minimally Invasive Obesity & Type 2 Diabetes Treatment

Post has attachment
BioSculpture Technology's plan to develop EVL to treat Obesity and Type II Diabetes

Post has attachment
Endoscopic Visceral Lipectomy, a a treatment for Obesity and Type II Diabetes mellitus under development.

Post has attachment
BioSculpture Technology, Inc. Investor highlights 9/10/16 update

Post has attachment
Highlights of BioSculpture Technology, Inc.'s Offering and Business plan to develop new minimally invasive treatment of obesity, metabolic syndrome and type 2 diabetes

Post has attachment
BioSculpture Technology, Inc. files Form 1-A for tier 2 Reg. A. Offering to commercialize its patented endoscopic treatment of obesity and type 2 diabetes.

Post has attachment
BioSculpture Technology, Inc. Files Form 1-A for Tier 2 Regulation A Offering to commercialize its patented minimally invasive obesity and type 2 diabetes treatment.

Post has attachment
Endoscopic Visceral Lipectomy as it might be carried out with BioSculpture Technology, Inc.'s EVL® DEVICE.
Wait while more posts are being loaded